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Sabina Šturm1*, iztok Grabnar2, Andrej Škibin3, Milan pogačnik1 & Vesna cerkvenik-flajs1
Dietary intake is the predominant route of human exposure to bisphenol A and one of the 
important food commodities is milk. the aim of our study was to preliminarily evaluate the bisphenol 
A exposure and disposition in sheep milk after repeated dietary and subcutaneous administration 
of a relatively low dose (100 µg/kg of b. w./day) of bisphenol A to a sheep. on the basis of blood 
plasma sampling, milk sampling and HpLc analysis, we developed the toxicokinetic model. With 
the toxicokinetic model we showed that most likely only free bisphenol A passes into the mammary 
gland and is subsequently conjugated there. the percentage of the dose eliminated with milk was less 
than 0.1%, regardless of the route of bisphenol A administration. It is proven that the bisphenol A is 
eliminated through the milk of lactating sheep. However, the amounts excreted in the milk that were 
detected in this study are minimal.
Since the start of the commercial production of bisphenol A (BPA) in the 1950s until the present, the global pro-
duction and consumption of this substance, regardless of the suspected negative health effects, has continued to 
rise1. With both the wide use of BPA and its leaching from many products and materials2, it is known to be one 
of the ubiquitous environmental contaminants3. The main route of human BPA exposure is thought to be oral 
ingestion (up to 83% of the total estimated exposure), and in 2013 canned products accounted for about 50% of 
the dietary exposure to BPA. Thus, cans and packaging are believed to be the main source of contamination in 
foods4. Current migration limit of BPA from varnishes or coatings applied to materials and articles is 0.05 mg/kg 
BPA of food5. However, the products from farm animals, being directly exposed to human pollution, could still 
be, in some cases, an additional risk factor for human exposure6.
It is believed that BPA causes endocrine disrupting effects by the interaction with various receptors, such as 
thyroid hormone receptor, androgen receptor and oestrogen receptor. Thus, BPA health hazards for reproductive 
system, nervous system, metabolic function, immune function, the growth and development of offspring were 
raised4,7. The European Food Safety Authority (EFSA) decreased the tolerable daily intake (TDI) from the 50 μg/
kg of b. w./day to 4 μg/kg of b. w./day as a response to a refined risk assessment of BPA7.
A food commodity important in our daily diet is milk. The quality and safety of milk depends considerably on 
the environment and human activity in its production. A broad range of environmental contaminants can enter 
the milk chain in the beginning via application of contaminated material on the soil such as industrial waste and 
sewage sludge, and atmospheric deposition from industrial activities6. It is also true that chemicals can enter milk 
during the collection and preparation processes of dairy products8. For instance, BPA may be introduced during 
milking from plastic parts of the milking machines, or also transferred from bulk milk to plastic storage tanks9. 
Finally, BPA can migrate as an additive from packaging material into the consumable milk. The actual levels of 
BPA found in commercial milk samples are presented in the review of Mercogliano and Santonicola, and are in 
the range between not detected (ND) to 521 ppb6.
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To the best of our knowledge, only a few in vivo studies are published regarding BPA transfer to milk, with all 
of them using rodent models, and all report limited excretion of BPA into milk10–13. Doerge et al. evaluated the 
lactational transfer of BPA after repeated oral dosing in rats, and found concentrations of 0.83 +/− 0.26 nM of 
free BPA and 7.6 +/− 2.8 nM of total BPA 1 hour after the administration of 100 µg/kg b. w.. They calculated that 
doses delivered to pups lactationally were 300-fold lower than the dose administered to the dams13.
Cows are mainly used in milk production in Europe, accounting for 96.9% of the total milk produced14. 
However, a significant part of the agrarian economies and sheep dairy products have gained market size due to 
the product’s quality, high yield, and high nutritional value15. Sheep are also frequently used as a model for cattle 
and other large mammals, due to their easier manipulation. The comparable digestive physiology (polygastric 
model) in sheep and cows enables the assumption that the sheep model is in terms of toxicokinetics (TK) a rele-
vant model for cows as well16.
The aim of our study was to estimate the transfer of BPA from feed or via subcutaneous administration to 
milk. To do so, one Slovenian autochthonous dairy sheep, an Istrian Pramenka, and her lamb were used in the 
study. Time courses of the free BPA, bisphenol A glucuronide (BPA-GLUC) and total BPA concentrations were 
followed in the ewe’s blood plasma after repeated dietary and subcutaneous administration, as well as BPA trans-
fer in milk. We also aimed to assess lactational transfer of BPA to the suckling lamb by estimating BPA exposure 
in its blood plasma. As gastrointestinal tract of our ruminant model is very specific and the detection of BPA or 
BPA-GLUC in the milk was never performed after in vivo experiment in this species, we were unable to predict 
the outcomes of the study. Thus, only one animal and only one concentration gradient (100 µg/kg b. w.) was used 
in this preliminary study.
Materials and methods
chemicals. Bisphenol A ≥ 99% purity (Merck, Sigma-Aldrich, Darmstadt, Germany) was dissolved in abso-
lute ethanol and corn oil for the dietary (po) and subcutaneous (sc) routes of administration, respectively. The 
volume administered to the sheep was adjusted to the body weight recorded on the day of the administration. For 
the dietary administration, approximately 1 mL of BPA solution in absolute ethanol was applied onto the pellet 
ration to obtain the single dose of 100 µg/kg b. w., and applied with the morning feed of pellets (400 g). For the sc 
administration, the injection of BPA solution was performed in the shoulder area (2.9 mL) at the same dose. Both 
solutions were stored at the ambient temperature in sealed amber glass bottles for the entire duration of use. All 
materials used for the solution preparation, sample processing and assays were either made of glass or of BPA-free 
plastics.
The dose of 100 μg/kg b. w. was chosen in this study. As it is within the linear pharmacokinetic range at a level 
as close as possible to the range of proposed human exposure, yet high enough to measure both aglycone (i.e., 
active) and conjugated (i.e., inactive) forms of BPA in samples analyzed13.
Animal husbandry. All animal procedures were carried out in accordance with ethical standards and 
approved by the Administration of the Republic of Slovenia for Food Safety, Veterinary Sector and Plant 
Protection with permission no. U34401-3/2015/8. The study was performed on one stabled, healthy lac-
tating Istrian Pramenka sheep with a single female suckling lamb in a sheepfold at the Infrastructure Centre 
for Sustainable Recultivation at Vremščica belonging to the Veterinary Faculty of the University of Ljubljana, 
Slovenia. The ewe was six years old and weighed 59 kg, while the suckling lamb was four weeks old and weighed 
12 kg. The ewe and lamb were kept under natural temperature and photoperiodic conditions, with free access to 
water, hay and salt. In addition, the sheep was fed twice a day with 400 g plant based pellets (SchafKorn Lac, Unser 
Lagerhaus Warenhandels Ges., Austria). Eventual contamination of the experimental environment was checked 
by preliminary testing of drinking water and pellets by high-performance liquid chromatography (HPLC) anal-
ysis, which revealed the slight presence of BPA of 0.02 µg/L and 5 µg/kg in these two matrices, respectively. The 
sheep and its lamb were, at both periods of the study, penned individually the day before the first administration 
until three days after the last administration. The lamb was kept with its mother, except on sampling days, when 
they were separated for a few hours before sampling time to collect enough milk for analysis. The animals were 
clinically healthy, as indicated by medical (temperature, breathing and rumination frequency, pulse rate) (see 
Supplementary Table S1), haematological and biochemical (see Supplementary Tables S2 and S3) examinations. 
Fourteen days after the second experimental period, the sheep and its lamb were released in their original herd.
experimental design. The experiment was divided into two periods, the first being the dietary administra-
tion period and the second being the subcutaneous administration period. The same ewe was used for both expo-
sure routes. Before the start of the second period, a 13 days wash-out period was permitted to ensure that BPA was 
removed from the body of the ewe. In the first period, the ewe received BPA in its diet (100 µg/day/kg b. w.) for 
five consecutive days (dietary route of administration). The ewe ingested all pellets within 2–9 minutes. During 
the second period, the same ewe was injected in the shoulder area with 100 µg/kg b. w. of BPA subcutaneously per 
day for five consecutive days (subcutaneous route of administration).
On the first day of the dietary period of the experiment, the ewe’s blood samples were taken at time 0 (before 
the first administration) and at 0.083, 0.16, 0.33, 0.5, 1, 2, 4, 6, 8, 10 and 24 hours after the first administration. 
The blood samples were then taken every day for the next seven days (trough concentrations). The sampling 
time started when the ewe ingested the whole portion of pellets. Similar sampling intervals were used in the 
second subcutaneous period of the experiment, with the exception of the first blood sampling (0.083 h after the 
sc administration), which was not taken. Blood samples from the suckling lamb were collected on the first day 
10 hours after BPA administration to the ewe, and on every following day before the next administration to the 
ewe. Jugular vein blood samples were collected in heparinised glass vacuum tubes, cooled to 4 °C and transported 
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to the laboratory where blood plasma was separated by centrifugation at 2640 × g for 15 min. The plasma was 
transferred and stored in polypropylene (PP) tubes. Plasma samples were kept frozen at −20 °C until analysis.
A diagram illustrating the design of the study, including the two experimental periods, BPA administration 
and blood sampling schedule of the ewe, is provided below (Fig. 1).
Milk sampling was done in both periods. The ewe was hand-milked. On the first day of the experiment milk 
was collected six and 10 hours after the first BPA administration and every next day just before the following 
administration. Before the first administration in each period the ewe was milked and then the lamb was sepa-
rated from the ewe during next six hours to allow estimation of the amount of BPA excreted in milk. The sampling 
period continued from the 5th until the 8th day of both periods, when there was no BPA administration. Milk was 
collected in PP containers and stored at −20 °C until analysis.
Blind samples of blood plasma from the sheep and suckling lamb and milk from the sheep were taken just 
before the start of both periods, to provide a baseline for the analysis.
The precautions taken to avoid contamination with BPA during sampling were: using glass vacuum tubes for 
blood collection and PP containers for milk collection.
free BpA and total BpA sample analysis. BPA stock solution of 200 µg/mL was prepared in acetonitrile, 
while the intermediate and working standard solutions ranging from 2,000 to 1.0 ng/mL were further prepared 
in a mixture of acetonitrile and water at a ratio of 35: 65 (v/v). Working standard solutions ranging from 50,000 
to 50 ng/mL for fortification of the total BPA samples were prepared in water with a small portion (≤20%, v/v) of 
ethanol or acetonitrile. All solutions were prepared using high purity deionised water obtained using a PureLab 
Option and PureLab Classic water purification system (Elga, Woodridge, Illinois, USA). The acetonitrile and 
methanol used were of HPLC gradient grade purity and purchased from J.T. Baker (Center Valley, PA, USA). 
Only high quality glass or labware were used for the sample analysis to avoid contamination with BPA during 
analysis.
Samples of the sheep blood plasma and milk were tested for the presence of both free (unconjugated) and 
total BPA (a sum of free and conjugated, mostly in a form of BPA-GLUC), of which the latter was determined 
indirectly by enzymatic conversion of the BPA-GLUC to free BPA. Sample aliquots of 1.5 and 5 mL were taken for 
the analysis of free BPA in the blood plasma and milk, respectively, while aliquots of 1.0 and 2.5 mL were taken to 
determine the total BPA and were diluted by 1.1 M Na-acetate buffer solution with pH values of 5.3 and 5.1 and 
volumes of 1.0 and 2.5 mL for the blood plasma and milk, respectively. Forty and 70 µL of ß-glucuronidase from 
Helix pomatia, type HP-2, ≥100,000 units/mL including also ≤7,500 sulfatase units/mL (Merck, Sigma-Aldrich, 
Darmstadt, Germany) were added to each sample of the blood plasma and milk, respectively. Samples were then 
incubated in a shaking water bath at 37 °C for 4 h.
The blood plasma and milk samples were further extracted by 6 and 10 mL of acetonitrile, respectively and 
ultrasonicated before being evaporated to dryness at 40–42 °C under a stream of N2 using an N-evap 111 evapora-
tor (Organomation Associates, Berlin, MA, USA). A further clean-up procedure included solid phase extraction 
(SPE) by the use of molecularly imprinted polymer (MIP) columns AFFINIMIP SPE Bisphenols, 6 mL, 100 mg 
(AFFINISEP, Petit-Couronne, France), while the additional use of a Chromabond HR-X phase, with 6 mL col-
umns, 200 mg, and 85 µm particle size (Macherey-Nagel, Düren, Germany) was previously utilised for all decon-
jugated sample extracts, as described by Deceuninck et al.17. Final SPE extracts were re-dissolved in acetonitrile/
H2O (35/65, v/v) as follows: both free BPA blood plasma and milk samples in 0.5 mL, and total BPA blood plasma 
and milk samples in 1.0 and 0.5 mL, respectively. Fifty µL of the final extract were taken for the HPLC analysis.
HPLC measurements were performed using a Varian ProStar HPLC system (Varian Analytical Instruments, 
Walnut Creek, CA, USA), comprised of a tertiary pump (240 model), automatic injector (410 model), fluo-
rescence detector (363 model), degasser and Galaxie 1.7.4.5 analytical software. Chromatographic separation 
was performed at room temperature by the gradient binary pumping of water and acetonitrile at a flow rate of 
1 mL/min through a Hypersil Gold C18 analytical column, 150 ×4.6 mm, with a particle size of 3 µm, which was 
Figure 1. Study design with two experimental periods, BPA administration and blood sampling schedule for 
the ewe.
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protected with Hypersil GOLD 3 µ Drop in the guards (Thermo Scientific, Waltham, MA, USA). The mobile 
phase gradient was as follows: 0–2 min, 35% (v/v) of acetonitrile, gradient to 12 min, 35–50% (v/v) of acetonitrile, 
held to 20 min, gradient to 20.5 min, 50–35% (v/v) of acetonitrile, held to 21 min. The excitation and emission 
wavelengths of the fluorescence spectrophotometry analysis were set at 230 and 315 nm, respectively18. The results 
were evaluated in accordance with the external standard method using a standard calibration curve as a function 
of chromatographic peak areas and standard concentrations. Each sample series consisted of a matrix sample, 
obtained before the first periodic BPA administration (a baseline sample), five to seven animal study samples in 
duplicate and two baseline matrix samples fortified with BPA to control the recovery rate. The measured sample 
concentrations were corrected for the possible baseline matrix response and for the mean recovery of the respec-
tive series and then used as final results.
Validation of the analytical methodology used was performed to demonstrate its fitness for the stated purpose. 
Linearity was determined by the least-squares method to calculate regression and correlation parameters for six 
to seven standard concentration points per calibration curve (range 1.0–100 ng/mL), and for both matrices as a 
correlation between measured and added concentrations (ranges 0.25–10 μg/L and 1.0–50 μg/L for free and total 
BPA in blood plasma, respectively, 0.5–15 μg/L for both free and total BPA in milk). Mean recovery was evalu-
ated by analysis of four to six fortified blank materials at two concentration levels at separate time points (blood 
plasma: free BPA 2 and 10 μg/L, total BPA 25 and 50 μg/L; milk: free BPA 2 and 5 μg/L, total BPA 5 and 10 μg/L). 
The within-laboratory reproducibility of the method was evaluated as the coefficient of variation (CV) of the 
determined and recovery values. The limit of detection (LOD) value was estimated as the BPA concentration in 
the retention time window where the analyte was to be expected, which corresponded to 3 × noise and was cor-
rected for the blank matrix response.
toxicokinetic analysis. Each entity (free BPA, BPA-GLUC, and total BPA) plasma concentration time 
course until the second BPA administration was first analysed using a noncompartmental approach to obtain 
the estimates of the area under the concentration–time curve extrapolated to infinity (AUC), maximum con-
centration in plasma and time when it occurs (cmax and tmax, respectively). AUC was calculated using the linear 
trapezoidal method and extrapolated to infinity by addition of the term Clast/λz, where Clast is the last quantified 
concentration measurement and λz is the terminal slope of the concentration profile in the semi-log plot cal-
culated by linear regression. tmax and cmax were reported as observed. AUC values were used to estimate clear-
ance (CL) as CL = Dose/AUCsc and relative bioavailability after dietary administration (Fr) as Fr = AUCpo/AUCsc. 
The indexes po and sc refer to the route of administration (dietary and subcutaneous, respectively) and Dose 
is the single BPA dose (100 µg/kg b. w.). Note that CL can be estimated only after intravenous administration. 
Our estimate of CL is therefore apparent clearance, i.e. assuming complete bioavailability after subcutaneous 
administration.
Subsequently, all TK data after both routes of administration were simultaneously fitted to a one- and 
two-compartment model with first-order absorption and elimination. The estimated parameters were CL, volume 
of the central and peripheral compartment (Vc and Vp, respectively), distribution clearance (Q), absorption rate 
constants after subcutaneous and dietary administration (ka sc and ka po, respectively) and relative bioavailability 
(Fr). Parameter fitting was performed using ADAPT II software19 with the maximum likelihood method and a 
proportional variance model, Vi = (σ × Yi)2, where Vi is the variance of the i-th data point and Yi is the value pre-
dicted by the model. The Akaike Information Criterion (AIC) value was used to select the model.
Permeation of free BPA, BPA-GLUC and total BPA into milk was modelled as a first order process dAm/dt = 
km × Cp(t), where dAm/dt is the transfer rate in µg/h, Cp(t) is the BPA plasma concentration at time t, and km is 
the transfer rate constant. km was estimated by simultaneous fitting of the amounts excreted into milk up to six 
hours after the first subcutaneous and dietary administration, with TK parameters for the plasma data fixed to 
previously estimated values. The amounts excreted in milk up to 6 h were approximated by multiplication of the 
concentration in milk at 6 h by 0.25 L, i.e. assuming an average milk yield of 1 L/day. We tested the hypothesis 
that only free BPA is transferred into milk and subsequently conjugated in the mammary gland, i.e. fixing the TK 
parameters to the values estimated for the free BPA versus the hypothesis that BPA-GLUC is also transferred, i.e. 
fixing the TK parameters to the values obtained for the conjugated and total BPA.
Results
Validation of the analytical methodology used. The validation parameters of the BPA blood plasma 
and milk analysis are presented in Table 1. The method was linear for BPA standards and matrices, as proved by 
the determination coefficients (r2) of ≥0.999 and ≥0.991, respectively. Mean recoveries for free and total BPA in 
the blood plasma were 82.3 and 49.5%, respectively and in the milk 62.9 and 54.3%, respectively. The total BPA 
refers to the sum of free and BPA-GLUC. The CVs of the concentrations detected and recovery in the fortified 
samples were from 1.5–24.4% under within-laboratory reproducibility conditions. The LOD values were 0.05–
0.1 µg/L and 0.2–0.4 µg/L for the free and total BPA determination, respectively, and differed according to a more 
comprehensive chromatographic background in the total BPA extracts.
tK analysis. BPA levels were checked before conducting both the first and second part of the experiment to 
provide a baseline for the analysis. The ewe entered the first part of the experiment with 0.05 and <0.4 µg/L of 
the free and total BPA in the blood plasma, respectively, and with <0.1 and 0.31 µg/L of the free and total BPA in 
milk, respectively. Just before the start of the subcutaneous administration, the ewe’s blood plasma contained 0.15 
and 0.72 µg/L of the free and total BPA, respectively, while its milk contained <0.1 and 0.35 µg/L of the free and 
total BPA, respectively.
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Comparison of the plasma concentration-time profiles. The maximum plasma concentration of free 
BPA obtained after subcutaneous administration was higher than after dietary administration. In addition, free 
BPA exposure was prolonged after subcutaneous administration compared to the dietary route of intake. With the 
dietary route, cmax of free BPA in plasma was 2.15 µg/L and was obtained very quickly, at 0.33 h. For the subcuta-
neous route, cmax of free BPA was 6.41 µg/L and was obtained after 2 h.
The cmax values of BPA-GLUC were similar for both routes of exposure and were 49.64 µg/L (tmax = 1 h) for 
subcutaneous administration and 41.3 µg/L (tmax = 0.33 h) for dietary administration.
The same seems to be valid for the cmax of total BPA, where cmax after subcutaneous administration was 
55.6 µg/L (tmax = 1 h) and cmax after dietary administration was 43.46 µg/L (tmax = 0.33 h).
The AUC of free BPA was 33.3 µg h/L for subcutaneous administration and 1.28 µg h/L for dietary administra-
tion. However, for BPA-GLUC and total BPA the AUC was 274 µg h/L and 307 µg h/L for subcutaneous adminis-
tration and 409 µg h/L and 410 µg h/L for dietary administration, respectively.
Administration by the subcutaneous route led to a higher overall internal exposure to free BPA and lower 
internal exposure to BPA-GLUC/total BPA compared to the dietary route.
Clearance and relative bioavailability of free BPA, BPA-GLUC and total BPA obtained with noncompartmen-
tal TK analysis are presented in Table 2.
The TK parameters obtained with the TK model of the free BPA, BPA-GLUC and total BPA are gath-
ered in Table 3. Blood plasma BPA-GLUC and total BPA concentration time courses were described with a 
one-compartment model, while a two-compartment model was more suitable for free BPA.
Figure 2 shows the plasma free BPA, BPA-GLUC and total BPA concentration-time profiles after repeated 
dietary and subcutaneous exposure of the ewe during the five days of a daily BPA administration of 100 µg/kg b. w. 
and the subsequent three days of no BPA administration. The concentration-time profiles between the two routes 
varied slightly for BPA-GLUC and total BPA, and markedly for the free BPA.
Parameter
Free BPA Total BPA






Range (µg/L) 0.25‒10 0.5‒15 1.0‒50 0.5‒-15




concentration (µg/L) 2 10 2 5 25 50 5 10
Recovery (s.d.) (%) 76.13 (2.26) 88.37 (1.29) 56.76 (13.83) 69.08 (11.90) 57.11 (13.64) 41.96 (2.99) 57.67 (8.53) 51.04 (10.61)
CV (%) 2.97 1.46 24.36 17.23 23.88 7.13 14.79 20.78
LOD (µg/L) 0.05 0.1 0.4 0.2
Table 1. Validation results of BPA determination in blood plasma and milk.
Parameter Free BPA BPA-conjugate Total BPA
Subcutaneous administration CL (L/h/kg) 3.0055 0.3650 0.3258
Dietary administration Fr (%) 3.8 149 134
Table 2. CL = clearance, Fr = relative bioavailability, dietary vs. subcutaneous administration. TK parameters of 
the noncompartmental TK analysis following the first dietary and subcutaneous BPA administration.
Parameter Free BPA BPA-GLUC Total BPA
CL (L/h/kg) 3.12 (7.2%) 0.388 (9.9%) 0.343 (9.1%)
Vc (L/kg) 2.45 (23.4%) 2.17 (13.3%) 1.89 (12.4%)
ka sc (h−1) 0.455 (16.1%) 2.57 (29.1%) 2.59 (27.1%)
Q (L/h/kg) 0.425 (39.4%) / /
Vp (L/kg) 5.75 (27.4%) / /
ka po (h−1) 6.39 (67.1%) 3.24 (19.2%) 3.44 (20.0%)
Fr (%) 4.52 (29.9%) 115 (12.9%) 101 (12.4%)
Table 3. CL = clearance, Vc = volume of central compartment, ka sc = absorption rate constant after 
subcutaneous administration, Q = distribution clearance, Vp = volume of peripheral compartment, ka 
po = absorption rate constant after dietary administration, Fr = relative bioavailability, dietary vs. subcutaneous 
administration, RSE = relative standard error, calculated by dividing standard error by mean value (%). TK 
parameters of the BPA (RSE%) following repeated dietary and subcutaneous administration.
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The ewe was administered 100 μg/kg b. w./day of BPA sc or po for five days, one time per day in the morning. 
The administration was stopped the sixth day of the experiment, while the sampling continued until the eighth 
day. Blood samples were collected at 0.08 – 0.17 – 0.33 – 0.5 – 1 – 2 – 4 – 6 – 8 – 10 – 23.33 – 46.58 – 69.35 – 92.35 
– 116.1 – 140.1 – 164.1 hours after the first dietary administration and 0.17 – 0.33 – 0.5 – 1 – 2 – 4 – 6 – 8 – 10 – 
23.92 – 47.84 – 71.34 – 95.17 – 118.67 – 143 – 167.5 hours after the first subcutaneous administration.
estimation of the free BpA, BpA-GLUc and total BpA elimination into the milk. Given our 
model assuming passive transfer (first-order) of BPA into milk, it is more likely that only free BPA is transferred 
into the mammary gland (AIC = −5.066 for the BPA-GLUC and AIC = −5.031 for the total BPA), versus the 
hypothesis that BPA-GLUC is also transported (AIC = −3.900 for the BPA-GLUC and AIC = −2.254 for the total 
Figure 2. Time course of free BPA (a), BPA-GLUC (b) and total BPA (c) plasma concentration.
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BPA). The estimated rate constants of transfer into milk (estimate (RSE%)) were 0.00832 L/h (0.1%) for the free 
BPA, 0.01839 L/h (3.6%) for the BPA-GLUC and 0.02669 L/h (2.4%) for the total BPA.
For the first part of the experiment (dietary administration), the percentage of the dose eliminated with milk 
was 0.0002% (RSE = 0.1%) for the free BPA, 0.00045% (RSE = 3.6%) for BPA-GLUC and 0.00066% (RSE = 24%) 
for total BPA.
For the second part of the experiment (subcutaneous administration), the percentage of the dose eliminated 
with milk was 0.00453% (RSE = 0.1%) for the free BPA, 0.01001% (RSE = 3.6%) for BPA-GLUC and 0.01452% 
(RSE = 2.4%) for total BPA.
Regarding the suckling lamb, which drank milk after its mother was administered with BPA by the dietary or 
subcutaneous routes, there were only traces of BPA in the samples of its plasma.
Discussion
The purpose of this study was to investigate the TK of BPA and to evaluate its elimination into the sheep milk after 
two different routes (po and sc) of repeated low dose BPA administration.
A comparison of the plasma concentration-time profile for the basic TK parameters of the two administra-
tion routes was made using the noncompartmental approach. Regarding the comparison of both routes of BPA 
administration, our preliminary findings are similar to those of Guignard et al.20, where the TK parameters for 
the same routes of administrations but with higher dose regimens were compared. The formulations for the die-
tary and as well for subcutaneous route of administration were similar in both studies. In our study, the cmax of 
free BPA for dietary administration was obtained quickly (0.33 h). In their study, mean cmax was attained 0.12 h 
for two ewes and 0.20 h for two others. For the subcutaneous route, cmax in our study was obtained after 2 h, in 
their study it was obtained after 2 h for three ewes and after 1 h for one ewe. In our study, the free BPA cmax for 
the subcutaneous route was three-fold higher than for the dietary route and in their work the free BPA cmax for 
the subcutaneous route was 4.6 ± 1.5-fold higher than for the dietary route. Our study demonstrates a higher 
cumulative (AUC) internal exposure to free BPA after subcutaneous administration compared to the dietary 
route, which is in line with the findings of Guignard et al.20. In their study, the relative bioavailability of BPA for 
the dietary as compared to subcutaneous route was 3.3 ± 0.3%. In our work, the relative bioavailability of BPA 
for the dietary as compared to subcutaneous route was 4.5%. Both this earlier work and the current study were 
also in agreement with regard to the BPA-GLUC concentration time course. Unlike free BPA, the BPA-GLUC 
concentration time courses are very similar for the two routes of exposure. Although our preliminary study was 
made with only one animal, the acquired data are in agreement with those of Guignard et al.20. This is impor-
tant, as measured concentrations from our study were the base for the TK model, which we used to evaluate the 
elimination of BPA into the sheep milk. Sampling of the milk was possible only at a couple of sampling points, 
and thus it was not possible to make time-concentration profiles for it. However, the measurments of BPA and 
BPA-GLUC in blood plasma and our TK model enabled us to estimate the percentage of the dose eliminated 
with milk, which was less than 0.1% for free BPA, BPA-GLUC and total BPA, regardless of the route of admin-
istration. This result is comparable with the results of Snyder et al., where they found only a small fraction of 
the 14C labelled BPA (0.63 +/− 0.13 µg/equiv/mL) 8 hours after dosing10. Regarding free BPA, BPA-GLUC and 
total BPA, it is already indirectly proven in rats that free BPA is transferred into the mammary gland to a greater 
extent than BPA-GLUC13,21. Given our TK models, the same was true in our study for the ewe. In the first model 
we were assuming passive transfer (first-order) of free BPA into milk, and in the second we were assuming that 
BPA-GLUC would also be transported. Based on the lower value of the Akaike information criterion (AIC), 
which is one of the indexes, which are showing model’s goddness of fit, in the first model, it is more likely that 
only free BPA is transferred into the mammary gland. Nevertheless, it was reported that the major molecular 
species in the milk of rats after oral administration of 14C-BPA was BPA-GLUC. The concentrations measured in 
milk six hours after BPA administration (dietary and subcutaneous) in our study show the same result. Six hours 
after dietary administration, the concentration of free BPA was 0.05 µg/L and the concentration of BPA-GLUC 
was 0.78 µg/L. Similarly, the concentrations of free BPA and BPA-GLUC after subcutaneous administration were 
0.87 and 1.89 µg/L, respectively. Regarding the BPA-GLUC in the milk, we hypothesise that free BPA is pas-
sively transferred into the mammary gland, and subsequently conjugated in its glucuronidated form presumably 
by the uridine 5′-diphospho-glucuronosyltransferase (UDP-glucuronosyltransferases) in the mammary gland. 
Only a few studies have evaluated UDP-glucuronosyltransferases (UGTs) presence in breast tissue. Expression 
of UGT2B10, UGT2B11, UGT2B15 and UGT2B UGT1A10 and UGT2B7, and UGT2B11 enzymes have been 
proven in humans, and the results of Street et al. confirm the capability of glucuronidation of BPA in human 
breast tissue, although with glucuronidation activities that are much lower (by more than 100,000-fold) compared 
with those seen in the liver22. There are currently no (to the best of our knowledge) known studies that have eval-
uated the presence of UDP-glucuronosyltransferases in the ewe mammary gland, although it seems reasonable 
to assume that the mammary glands of all mammals are equipped with comparable detoxifying mechanisms.
The above mentioned concentrations of free BPA measured in this study are well within the range with the 
concentrations found in raw milk measured in a recent Italian monitoring study, where the concentrations of free 
BPA ranged from 0.081–2.492 µg/L23. However, the concentrations measured in commercial milk samples were 
generally higher (from 14.0 to 521.0 µg/L)6, meaning that the BPA load in consumption milk is greater at the end 
of the production line and during further processing.
We report that three years after the end of the experiment, the ewe and the lamb are in a good health condi-
tion. There were no reproductive abnormalities reported in the ewe in the past three years. After the experiment, 
the ewe had offspring each year. In the year 2018, the offspring were two healthy male lambs, while in the year 
2019, the offspring were one healthy male and one healthy female lamb. The grown-up lamb developed normally, 
has been recently mated for the first time and is currently pregnant (12. 3. 2020). Both animals have appropriate 
body weight and there is no known history of disease.
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conclusion
In this preliminary study, we are presenting the detected BPA and BPA-GLUC concentrations in the milk sam-
ples obtained from the ewe administered by two different routes of administration. With the TK model, on the 
basis of blood plasma and milk measurements, we were able to estimate the percentage of the eliminated BPA in 
the milk, which is minimal regardless of the administered route of BPA. In addition, with our TK model we can 
suggest that in sheep, being a large animal model, BPA is transferred in the milk in the mammary gland mostly 
in its free form. As BPA-GLUC concentrations were higher than free BPA concentrations in milk, and that with 
regards to our TK model, only BPA can cross the barrier between blood and mammary gland, we are estimating 
that free BPA is probably subsequently metabolised in mammary gland. Further studies are needed to confirm 
preliminary findings in this study, especially in a view of greater number of animals, different phases of lactation 
and different BPA doses.
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